Clinical outcome measures following plasma exchange for MG exacerbation

Our objective is to report longitudinal results of the MG‐ADL, MG‐Composite, MG‐MMT, and MG‐QoL15 in an open‐label trial of therapeutic plasma exchange in myasthenia gravis. Ten MG patients experiencing exacerbation had assessments prior to, immediately following, and at selected time points post‐TP...

Descripción completa

Detalles Bibliográficos
Autores principales: Raja, Shruti M., Howard, James F., Juel, Vern C., Massey, Janice M., Chopra, Manisha, Guptill, Jeffrey T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801175/
https://www.ncbi.nlm.nih.gov/pubmed/31560178
http://dx.doi.org/10.1002/acn3.50901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801175/
https://www.ncbi.nlm.nih.gov/pubmed/31560178
http://dx.doi.org/10.1002/acn3.50901

Ejemplares similares